Investing.com -- Piper Sandler upgraded Qorvo Inc (NASDAQ:QRVO) shares to "overweight" on potential operational and capital efficiencies driven by Starboard Value’s recent involvement.

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,013.00. The company’s shares closed last Friday at ...

Investing.com -- Piper Sandler analysts downplayed concerns about the potential impact of DeepSeek's AI advancements on Tesla (NASDAQ:TSLA), concluding the implications are "neutral at worst." ...

On Monday, Piper Sandler analyst Charles Neivert adjusted the investment firm's stance on Mosaic (NYSE: MOS), upgrading the stock from Underweight to Neutral with a price target (PT) set at $30.00.

Piper Sandler analyst Frank Schiraldi maintained a Hold rating on Valley National Bancorp (VLY – Research Report) today and set a price target of $11.00. The company’s shares closed last ...

Trupanion (NASDAQ:TRUP) shares rallied more than 4% Thursday following an upgrade from Piper Sandler analysts, who shifted their rating to Overweight from Neutral. In a note, the analysts cited ...

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2024 financial results prior to the opening of the ...

Investing.com -- Piper Sandler downgraded Biogen Inc (NASDAQ:BIIB) from “overweight” to “neutral,” given a challenging transition period for the biotech firm. The brokerage hacked the ...

Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several favorable catalysts. The catalysts include the 2025 guidance, faster-than ...

On Monday, Piper Sandler analyst Charles Neivert adjusted the investment firm's stance on Mosaic (NYSE: MOS), upgrading the stock from Underweight to Neutral with a price target (PT) set at $30.00.

Piper Sandler downgraded Biogen (NASDAQ:BIIB) to neutral from overweight on Thursday, citing, among other things, the company's challenges in establishing its presence in the market for Alzheimer ...

Piper Sandler upgraded shares of Aptiv (NYSE:APTV – Free Report) from an underweight rating to a neutral rating in a research note published on Thursday morning, MarketBeat.com reports.